Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Fujitsu and Fujitsu System Solutions have launched software as a service (SaaS)-based solution to support the operation of clinical drug trials conducted by pharmaceutical companies. The new service, known as tsClinical, is now available in Japan.
Subscribe to our email newsletter
tsClinical is an on-demand SaaS-based solution that provides a data management system for results from medical cases necessary for clinical trials of new drugs, according to trial length and scale, through a network.
The new service eliminates the need for users to deploy an individual case data management system for each clinical trial, thus speeding up the trial process. It eliminates system deployment and maintenance costs, and minimizes the workload associated with clinical trials.
The company said that tsClinical has already been deployed by Bellsystem24, a Japan-based organization that provides support services for clinical trials. In addition to existing support services, Bellsystem24 aims to deliver enhanced CRO) services by providing new services, connecting its pharmaceutical customers with a data management environment through SaaS.
To optimize clinical trial operations during new drug development, Fujitsu is offering an on-demand SaaS-based data management system, which previously was only available as a software package.